Ellen Capon (Drug Target Review)2024-01-22T14:00:17
Researchers have made surprising and important findings that may influence organoid and cell reprogramming studies.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-08-20T08:43:00Z
Author Dr Daniel Tillett
2024-01-24T12:52:38
Sponsored by BellBrook Labs
2023-02-23T14:02:18
Sponsored by bit.bio
2025-05-08T10:38:52
Sponsored by Takara Bio USA
2025-04-02T14:00:00
Sponsored by Eurofins Discovery
2024-01-19T07:40:55
Sponsored by Euretos
2024-05-07T13:11:19
Sponsored by BellBrook Labs
Site powered by Webvision Cloud